Beta-thalassemia surgery: Difference between revisions

Jump to navigation Jump to search
 
(10 intermediate revisions by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
Surgical intervention is frequently required to guarantee optimum management of the accompanying morbidity in beta-thalassemia cases. The most prevalent types of surgical interventions associated with beta-thalassemia include [[splenectomy]], [[cholecystectomy]], leg ulcers, fractures, and extramedullary pseudotumor.


==Surgery==
==Surgery==


Surgical intervention is frequently required to guarantee optimum management of the accompanying morbidity in TI cases. Before undergoing surgical intervention, there are a few things of a more general nature that need to be taken into mind:
Surgical intervention is frequently required to guarantee optimum management of the accompanying morbidity in beta-thalassemia cases. Before undergoing surgical intervention, there are a few things of a more general nature that need to be taken into mind:
*Anemia
*[[Anemia]]
*Cardiovascular disease
*[[Cardiovascular disease]]
*Thromboembolic events
*Thromboembolic events
*The consequences of iron overload
*The consequences of iron overload


The most prevalent types of surgical complications associated with TI include:
The most prevalent types of surgical interventions associated with beta-thalassemia include:
*Splenectomy
*[[Splenectomy]]: In severe cases with significant [[splenomegaly]], splenectomy may be considered. This would help improve [[anemia]] and reduce transfusion requirements.
*Cholecystectomy
*[[Cholecystectomy]]: Recurrent [[gallstone]] due to chronic [[hemolysis]].
*Leg ulcers
*Leg ulcers
*Fractures
*Fractures
*Extramedullary pseudotumor<ref name="pmid21480198">{{cite journal |vauthors=Saad GS, Musallam KM, Taher AT |title=The surgeon and the patient with β-thalassaemia intermedia |journal=Br J Surg |volume=98 |issue=6 |pages=751–60 |date=June 2011 |pmid=21480198 |doi=10.1002/bjs.7533 |url=}}</ref></ref><ref name="pmid34738740">{{cite journal |vauthors=Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi SAR, Sadia, Irfan M, Khan MA |title=Current status of beta-thalassemia and its treatment strategies |journal=Mol Genet Genomic Med |volume=9 |issue=12 |pages=e1788 |date=December 2021 |pmid=34738740 |pmc=8683628 |doi=10.1002/mgg3.1788 |url=}}</ref>
*Extramedullary pseudotumor<ref name="pmid21480198">{{cite journal |vauthors=Saad GS, Musallam KM, Taher AT |title=The surgeon and the patient with β-thalassaemia intermedia |journal=Br J Surg |volume=98 |issue=6 |pages=751–60 |date=June 2011 |pmid=21480198 |doi=10.1002/bjs.7533 |url=}}</ref><ref name="pmid34738740">{{cite journal |vauthors=Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi SAR, Sadia, Irfan M, Khan MA |title=Current status of beta-thalassemia and its treatment strategies |journal=Mol Genet Genomic Med |volume=9 |issue=12 |pages=e1788 |date=December 2021 |pmid=34738740 |pmc=8683628 |doi=10.1002/mgg3.1788 |url=}}</ref><ref name="pmid31030806">{{cite journal |vauthors=Khandros E, Kwiatkowski JL |title=Beta Thalassemia: Monitoring and New Treatment Approaches |journal=Hematol Oncol Clin North Am |volume=33 |issue=3 |pages=339–353 |date=June 2019 |pmid=31030806 |doi=10.1016/j.hoc.2019.01.003 |url=}}</ref>.


==References==
==References==

Latest revision as of 05:57, 25 August 2023

Beta-thalassemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Beta-thalassemia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Beta-thalassemia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Beta-thalassemia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Beta-thalassemia surgery

CDC on Beta-thalassemia surgery

Beta-thalassemia surgery in the news

Blogs on Beta-thalassemia surgery

Directions to Hospitals Treating Beta-thalassemia

Risk calculators and risk factors for Beta-thalassemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

Surgical intervention is frequently required to guarantee optimum management of the accompanying morbidity in beta-thalassemia cases. The most prevalent types of surgical interventions associated with beta-thalassemia include splenectomy, cholecystectomy, leg ulcers, fractures, and extramedullary pseudotumor.

Surgery

Surgical intervention is frequently required to guarantee optimum management of the accompanying morbidity in beta-thalassemia cases. Before undergoing surgical intervention, there are a few things of a more general nature that need to be taken into mind:

The most prevalent types of surgical interventions associated with beta-thalassemia include:

References

  1. Saad GS, Musallam KM, Taher AT (June 2011). "The surgeon and the patient with β-thalassaemia intermedia". Br J Surg. 98 (6): 751–60. doi:10.1002/bjs.7533. PMID 21480198.
  2. Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi S, Sadia, Irfan M, Khan MA (December 2021). "Current status of beta-thalassemia and its treatment strategies". Mol Genet Genomic Med. 9 (12): e1788. doi:10.1002/mgg3.1788. PMC 8683628 Check |pmc= value (help). PMID 34738740 Check |pmid= value (help). Vancouver style error: initials (help)
  3. Khandros E, Kwiatkowski JL (June 2019). "Beta Thalassemia: Monitoring and New Treatment Approaches". Hematol Oncol Clin North Am. 33 (3): 339–353. doi:10.1016/j.hoc.2019.01.003. PMID 31030806.


Template:WikiDoc Sources